Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Biperidene Lactate
1. Akineton
2. 09td6c5147
3. 1-piperidinepropanol, Alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-, Compd. With 2-hydroxypropanoic Acid (1:1)
4. Tasmolin (tn)
5. Akineton Lactate
6. Einecs 230-388-9
7. Biperidenlactat
8. Unii-09td6c5147
9. Biperiden Lactate [usp:ban:jan]
10. Biperidenlactate
11. Alpha-5-norbornen-2-yl-alpha-phenyl-1-piperidinepropanol Lactate (salt)
12. Alpha-5-norbornen-2-yl-alpha-phenyl-1-piperidinepropanol Compd. With Lactic Acid (1:1)
13. Schembl41834
14. Biperiden Lactate (jan/usp)
15. Biperiden Lactate [jan]
16. Chembl1201067
17. Biperiden Lactate [vandf]
18. Dtxsid40991120
19. Biperiden Lactate [mart.]
20. Biperiden Lactate [who-dd]
21. Hy-13204b
22. Biperiden Lactate [orange Book]
23. Biperiden Lactate [usp Impurity]
24. Lactic Acid, Compd. With Alpha-5-norbornen-2-yl-alpha-phenyl-1-piperidinepropanol (1:1)
25. Lactic Acid, Compound With Alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenylpiperidin-1-propanol (1:1)
26. Cs-0030940
27. D02247
28. Q27236503
29. .alpha.-5-norbornen-2-yl-.alpha.-phenyl-1-piperidinepropanol Lactate (salt)
30. 1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol;2-hydroxypropanoic Acid
31. 1-piperidinepropanol, .alpha.-bicyclo(2.2.1)hept-5-en-2-yl-.alpha.-phenyl-, Compd. With 2-hydroxypropanoic Acid (1:1)
| Molecular Weight | 401.5 g/mol |
|---|---|
| Molecular Formula | C24H35NO4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 401.25660860 g/mol |
| Monoisotopic Mass | 401.25660860 g/mol |
| Topological Polar Surface Area | 81 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 481 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 5 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Biperiden Lactate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Biperiden Lactate, including repackagers and relabelers. The FDA regulates Biperiden Lactate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Biperiden Lactate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Biperiden Lactate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Biperiden Lactate supplier is an individual or a company that provides Biperiden Lactate active pharmaceutical ingredient (API) or Biperiden Lactate finished formulations upon request. The Biperiden Lactate suppliers may include Biperiden Lactate API manufacturers, exporters, distributors and traders.
click here to find a list of Biperiden Lactate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Biperiden Lactate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Biperiden Lactate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Biperiden Lactate GMP manufacturer or Biperiden Lactate GMP API supplier for your needs.
A Biperiden Lactate CoA (Certificate of Analysis) is a formal document that attests to Biperiden Lactate's compliance with Biperiden Lactate specifications and serves as a tool for batch-level quality control.
Biperiden Lactate CoA mostly includes findings from lab analyses of a specific batch. For each Biperiden Lactate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Biperiden Lactate may be tested according to a variety of international standards, such as European Pharmacopoeia (Biperiden Lactate EP), Biperiden Lactate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Biperiden Lactate USP).
LOOKING FOR A SUPPLIER?
